- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 17/10 - Anti-acne agents
Patent holdings for IPC class A61P 17/10
Total number of patents in this class: 1545
10-year publication summary
|
61
|
56
|
65
|
115
|
142
|
158
|
156
|
168
|
105
|
42
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Galderma Research & Development | 440 |
71 |
| Sol-gel Technologies Ltd. | 170 |
37 |
| Pierre Fabre Dermo-Cosmetique | 380 |
28 |
| Johnson & Johnson Consumer Inc. | 1277 |
26 |
| Beiersdorf AG | 2963 |
22 |
| DSM IP Assets B.V. | 5856 |
21 |
| Galderma S.A. | 174 |
18 |
| S-Biomedic NV | 35 |
18 |
| Conopco, Inc. | 4644 |
17 |
| The Regents of the University of California | 18943 |
17 |
| Allergan, Inc. | 2600 |
16 |
| Unilever Global IP Limited | 1949 |
15 |
| Bausch Health Ireland Limited | 751 |
14 |
| L' Oréal | 5103 |
13 |
| Novartis AG | 11238 |
11 |
| Galderma Holding S.A. | 711 |
10 |
| Unilever IP Holdings B.V. | 3021 |
10 |
| Dr. Reddy's Laboratories Limited | 551 |
9 |
| Maruho Co., Ltd. | 95 |
9 |
| Eligo Bioscience | 87 |
9 |
| Other owners | 1154 |